| Revenue | — | — |
| EBITDA | DKK -10K | +20% |
| Net profit | DKK 46,8M | +6% |
| Total assets | DKK 125,4M | +13% |
| Equity | DKK 125,3M | +13% |
| Employees | — | — |
| Item | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|
| Revenue | 3 | -18 | — | — |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | 3 | -18 | -12 | -10 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 3 | -18 | -12 | -10 |
| Net financials | 26.446 | 41.397 | 44.305 | 46.801 |
| Profit before tax | 26.449 | 41.379 | 44.293 | 46.791 |
| Tax | -0 | -6 | -3 | -3 |
| Net profit | 26.450 | 41.384 | 44.296 | 46.794 |
| Item | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|
| Total assets | 74.673 | 97.433 | 111.298 | 125.443 |
| Equity | 74.575 | 97.334 | 111.197 | 125.335 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 98 | 98 | 101 | 108 |
| Total debt | 98 | 98 | 101 | 108 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PL Management | Management | 2012 | — | — |
PG Management | Management | 2003 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
KE Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — | |
| Board of Directors | 2012 | — | — | |
| Deputy Chairman | 2012 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
MISSIONPHARMA GROUP ApS | Company | 100.0% | 100.0% | 2006 |
| Person | Role here | Other companies |
|---|---|---|
| Poul Lindof | Management | 0 companies |
| Paule Georgette Ginnerup | Management | 0 companies |
| Mikkel Mørkedal Wakefield | Chief Executive Officer | 0 companies |
| Kim Erik Ginnerup | Chief Executive Officer | 0 companies |
| Jean-Marc Pierre Rene Leccia | Chairman | 0 companies |
| Eric Pierre Jean Muris | Board of Directors | 0 companies |
| Denis Georges Fernand Maurice | Deputy Chairman | 0 companies |